F McDowall1,2, K Kenny1, A J Mighell3, R C Balmer1,2. 1. Paediatric Dentistry Department, Leeds Dental Institute, University of Leeds, United Kingdom. 2. Harrogate and District Foundation Trust, North Yorkshire Community Dental Services, United Kingdom. 3. Oral Medicine Department, Leeds School of Dentistry, University of Leeds, United Kingdom.
Abstract
Introduction: Genetic testing is increasingly applied across healthcare reflecting the value to diagnosis, clinical decision-making, service organisation and advancement of the research-informed evidence base. Patient expectations are changing. Genetic testing has not been part of dental practice. Introduction of an NHS-targeted gene panel test for amelogenesis imperfecta (AI), a heterogeneous genetic disorder affecting enamel appearance and function, represents a paradigm shift. This impacts on specialists in paediatric dentistry and other members of the dental team delivering longitudinal care for individuals with AI. Aim: To evaluate the opinions of paediatric dentists on genetic testing for dental conditions using AI as the exemplar. Method: Two focus groups of nine UK NHS paediatric dentists each were audio recorded (September 2016) and transcribed verbatim. Qualitative analysis was undertaken using Interpretative Phenomenological Analysis (IPA). Results: A wide range of views reflected existing insight and understanding. Three core concepts of justification, ownership and challenges emerged. The clinicians were generally open to involvement with genetic testing in paediatric dentistry, but required more support. Conclusion: Areas for clarification and professional development were identified as important in ensuring that genetic testing in dentistry, which is currently in its infancy, reaches translational potential and enhances patient care as this area of healthcare continues to advance rapidly.
Introduction: Genetic testing is increasingly applied across healthcare reflecting the value to diagnosis, clinical decision-making, service organisation and advancement of the research-informed evidence base. Patient expectations are changing. Genetic testing has not been part of dental practice. Introduction of an NHS-targeted gene panel test for amelogenesis imperfecta (AI), a heterogeneous genetic disorder affecting enamel appearance and function, represents a paradigm shift. This impacts on specialists in paediatric dentistry and other members of the dental team delivering longitudinal care for individuals with AI. Aim: To evaluate the opinions of paediatric dentists on genetic testing for dental conditions using AI as the exemplar. Method: Two focus groups of nine UK NHS paediatric dentists each were audio recorded (September 2016) and transcribed verbatim. Qualitative analysis was undertaken using Interpretative Phenomenological Analysis (IPA). Results: A wide range of views reflected existing insight and understanding. Three core concepts of justification, ownership and challenges emerged. The clinicians were generally open to involvement with genetic testing in paediatric dentistry, but required more support. Conclusion: Areas for clarification and professional development were identified as important in ensuring that genetic testing in dentistry, which is currently in its infancy, reaches translational potential and enhances patient care as this area of healthcare continues to advance rapidly.
Authors: Kristina D Coffield; Ceib Phillips; Melissa Brady; Michael W Roberts; Ronald P Strauss; J Timothy Wright Journal: J Am Dent Assoc Date: 2005-05 Impact factor: 3.634
Authors: Graciana Jaureguiberry; Muriel De la Dure-Molla; David Parry; Mickael Quentric; Nina Himmerkus; Toshiyasu Koike; James Poulter; Enriko Klootwijk; Steven L Robinette; Alexander J Howie; Vaksha Patel; Marie-Lucile Figueres; Horia C Stanescu; Naomi Issler; Jeremy K Nicholson; Detlef Bockenhauer; Christopher Laing; Stephen B Walsh; David A McCredie; Sue Povey; Audrey Asselin; Arnaud Picard; Aurore Coulomb; Alan J Medlar; Isabelle Bailleul-Forestier; Alain Verloes; Cedric Le Caignec; Gwenaelle Roussey; Julien Guiol; Bertrand Isidor; Clare Logan; Roger Shore; Colin Johnson; Christopher Inglehearn; Suhaila Al-Bahlani; Matthieu Schmittbuhl; François Clauss; Mathilde Huckert; Virginie Laugel; Emmanuelle Ginglinger; Sandra Pajarola; Giuseppina Spartà; Deborah Bartholdi; Anita Rauch; Marie-Claude Addor; Paulo M Yamaguti; Heloisa P Safatle; Ana Carolina Acevedo; Hercílio Martelli-Júnior; Pedro E dos Santos Netos; Ricardo D Coletta; Sandra Gruessel; Carolin Sandmann; Denise Ruehmann; Craig B Langman; Steven J Scheinman; Didem Ozdemir-Ozenen; Thomas C Hart; P Suzanne Hart; Ute Neugebauer; Eberhard Schlatter; Pascal Houillier; William A Gahl; Miikka Vikkula; Agnès Bloch-Zupan; Markus Bleich; Hiroshi Kitagawa; Robert J Unwin; Alan Mighell; Ariane Berdal; Robert Kleta Journal: Nephron Physiol Date: 2013-02-23
Authors: Claire E L Smith; James A Poulter; Agne Antanaviciute; Jennifer Kirkham; Steven J Brookes; Chris F Inglehearn; Alan J Mighell Journal: Front Physiol Date: 2017-06-26 Impact factor: 4.566